Exploring mechanisms of FGF signalling through the lens of structural biology (original) (raw)

• Itoh, N. & Ornitz, D. M. Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J. Biochem. 149, 121–130 (2011).
  Article CAS PubMed Google Scholar
• Mohammadi, M., Olsen, S. K. & Ibrahimi, O. A. Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev. 16, 107–137 (2005).
  Article CAS PubMed Google Scholar
• Itoh, N. & Ornitz, D. M. Evolution of the Fgf and Fgfr gene families. Trends Genet. 20, 563–569 (2004).
  Article CAS PubMed Google Scholar
• Schlessinger, J. et al. Crystal structure of a ternary FGF–FGFR–heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell 6, 743–750 (2000). Reveals the structural basis by which heparan sulphate promotes ligand-induced FGFR dimerization.
  Article CAS PubMed Google Scholar
• Chen, H. et al. A crystallographic snapshot of tyrosine _trans_-phosphorylation in action. Proc. Natl Acad. Sci. USA 105, 19660–19665 (2008).
  Article PubMed PubMed Central Google Scholar
• Furdui, C. M., Lew, E. D., Schlessinger, J. & Anderson, K. S. Autophosphorylation of FGFR1 kinase is mediated by a sequential and precisely ordered reaction. Mol. Cell 21, 711–717 (2006).
  Article CAS PubMed Google Scholar
• Gotoh, N. Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins. Cancer Sci. 99, 1319–1325 (2008).
  Article CAS PubMed Google Scholar
• Carpenter, G. & Ji, Q. Phospholipase C-γ as a signal-transducing element. Exp. Cell Res. 253, 15–24 (1999).
  Article CAS PubMed Google Scholar
• Bottcher, R. T. & Niehrs, C. Fibroblast growth factor signaling during early vertebrate development. Endocr. Rev. 26, 63–77 (2005).
  Article CAS PubMed Google Scholar
• Thisse, B. & Thisse, C. Functions and regulations of fibroblast growth factor signaling during embryonic development. Dev. Biol. 287, 390–402 (2005).
  Article CAS PubMed Google Scholar
• Turner, N. & Grose, R. Fibroblast growth factor signalling: from development to cancer. Nature Rev. Cancer 10, 116–129 (2010).
  Article CAS Google Scholar
• Asada, M. et al. Glycosaminoglycan affinity of the complete fibroblast growth factor family. Biochim. Biophys. Acta 1790, 40–48 (2009).
  Article CAS PubMed Google Scholar
• Perrimon, N. & Bernfield, M. Specificities of heparan sulphate proteoglycans in developmental processes. Nature 404, 725–728 (2000).
  Article CAS PubMed Google Scholar
• Goetz, R. et al. Molecular insights into the Klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol. Cell. Biol. 27, 3417–3428 (2007). Reveals the structural basis for the endocrine mode of action of FGF19 subfamily ligands.
  Article CAS PubMed PubMed Central Google Scholar
• Rapraeger, A. C., Krufka, A. & Olwin, B. B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252, 1705–1708 (1991).
  Article CAS PubMed Google Scholar
• Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P. & Ornitz, D. M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841–848 (1991).
  Article CAS PubMed Google Scholar
• Ding, X. et al. βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism. Cell Metab. 16, 387–393 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Kurosu, H. et al. Tissue-specific expression of βKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J. Biol. Chem. 282, 26687–26695 (2007).
  Article CAS PubMed Google Scholar
• Kurosu, H. et al. Regulation of fibroblast growth factor-23 signaling by Klotho. J. Biol. Chem. 281, 6120–6123 (2006).
  Article CAS PubMed Google Scholar
• Nakatani, T., Ohnishi, M. & Razzaque, M. S. Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model. FASEB J. 23, 3702–3711 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ogawa, Y. et al. βKlotho is required for metabolic activity of fibroblast growth factor 21. Proc. Natl Acad. Sci. USA 104, 7432–7437 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Tomiyama, K. et al. Relevant use of Klotho in FGF19 subfamily signaling system in vivo. Proc. Natl Acad. Sci. USA 107, 1666–1671 (2010).
  CAS PubMed PubMed Central Google Scholar
• Urakawa, I. et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444, 770–774 (2006).
  Article CAS PubMed Google Scholar
• Dorey, K. & Amaya, E. FGF signalling: diverse roles during early vertebrate embryogenesis. Development 137, 3731–3742 (2010).
  Article CAS PubMed Google Scholar
• Hart, A. W., Baeza, N., Apelqvist, A. & Edlund, H. Attenuation of FGF signalling in mouse β-cells leads to diabetes. Nature 408, 864–868 (2000). Identifies a crucial role for FGF signalling in pancreatic β-cell function and glucose homeostasis in the adult.
  Article CAS PubMed Google Scholar
• Jonker, J. W. et al. A PPARγ–FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis. Nature 485, 391–394 (2012). Identifies a crucial role for FGF1 in the remodelling of adipose tissue in response to fluctuating nutrient availability.
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, M. et al. Fibroblast growth factor 2 control of vascular tone. Nature Med. 4, 201–207 (1998).
  Article CAS PubMed Google Scholar
• Sakaue, H. et al. Requirement of fibroblast growth factor 10 in development of white adipose tissue. Genes Dev. 16, 908–912 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Potthoff, M. J., Kliewer, S. A. & Mangelsdorf, D. J. Endocrine fibroblast growth factors 15/19 and 21: from feast to famine. Genes Dev. 26, 312–324 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Quarles, L. D. Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism. Nature Rev. Endocrinol. 8, 276–286 (2012).
  Article CAS Google Scholar
• Razzaque, M. S. The FGF23–Klotho axis: endocrine regulation of phosphate homeostasis. Nature Rev. Endocrinol. 5, 611–619 (2009).
  Article CAS Google Scholar
• Long, Y. C. & Kharitonenkov, A. Hormone-like fibroblast growth factors and metabolic regulation. Biochim. Biophys. Acta 1812, 791–795 (2011).
  Article CAS PubMed Google Scholar
• Beenken, A. & Mohammadi, M. The FGF family: biology, pathophysiology and therapy. Nature Rev. Drug Discov. 8, 235–253 (2009).
  Article CAS Google Scholar
• Wilkie, A. O. Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev. 16, 187–203 (2005).
  Article CAS Google Scholar
• Goetz, R. et al. Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23–FGFR–Klotho complex formation. Proc. Natl Acad. Sci. USA 107, 407–412 (2010).
  Article PubMed Google Scholar
• Kalinina, J. et al. Homodimerization controls the fibroblast growth factor 9 subfamily's receptor binding and heparan sulfate-dependent diffusion in the extracellular matrix. Mol. Cell. Biol. 29, 4663–4678 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Olsen, S. K. et al. Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain. Genes Dev. 20, 185–198 (2006). Identifies the molecular mechanism by which N-terminal splicing regulates the biological activity of FGF8 and provides structural evidence for ligand-induced differences in FGFR dimerization.
  Article CAS PubMed PubMed Central Google Scholar
• Plotnikov, A. N. et al. Crystal structure of fibroblast growth factor 9 reveals regions implicated in dimerization and autoinhibition. J. Biol. Chem. 276, 4322–4329 (2001).
  Article CAS PubMed Google Scholar
• Yeh, B. K. et al. Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors. Proc. Natl Acad. Sci. USA 100, 2266–2271 (2003). Reveals the molecular basis by which alternative splicing in the D3 domain of FGFR2 regulates the ligand-binding specificity of this receptor.
  Article CAS PubMed PubMed Central Google Scholar
• Gallagher, J. T. Heparan sulfate: growth control with a restricted sequence menu. J. Clin. Invest. 108, 357–361 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Chen, Y., Mohammadi, M. & Flanagan, J. G. Graded levels of FGF protein span the midbrain and can instruct graded induction and repression of neural mapping labels. Neuron 62, 773–780 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Harada, M. et al. FGF9 monomer–dimer equilibrium regulates extracellular matrix affinity and tissue diffusion. Nature Genet. 41, 289–298 (2009).
  Article CAS PubMed Google Scholar
• Makarenkova, H. P. et al. Differential interactions of FGFs with heparan sulfate control gradient formation and branching morphogenesis. Sci. Signal. 2, ra55 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Qu, X. et al. Lacrimal gland development and Fgf10–Fgfr2b signaling are controlled by 2-_O_- and 6-_O_-sulfated heparan sulfate. J. Biol. Chem. 286, 14435–14444 (2011). Demonstrates that a specific fine structure of the heparan sulphate produced by the cell responding to an FGF ligand is required for FGF signalling.
  Article CAS PubMed PubMed Central Google Scholar
• Qu, X. et al. Glycosaminoglycan-dependent restriction of FGF diffusion is necessary for lacrimal gland development. Development 139, 2730–2739 (2012). Demonstrates that the heparan sulphate produced by the cell secreting an FGF ligand mediates the formation of an FGF gradient in the extracellular matrix and that its fine structure is a crucial determinant in this process.
  Article CAS PubMed PubMed Central Google Scholar
• Murakami, H. et al. Elbow knee synostosis (Eks): a new mutation on mouse chromosome 14. Mamm. Genome 13, 341–344 (2002).
  Article PubMed Google Scholar
• Crossley, P. H. & Martin, G. R. The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo. Development 121, 439–451 (1995).
  CAS PubMed Google Scholar
• Gemel, J., Gorry, M., Ehrlich, G. D. & MacArthur, C. A. Structure and sequence of human FGF8. Genomics 35, 253–257 (1996).
  Article CAS PubMed Google Scholar
• MacArthur, C. A. et al. FGF-8 isoforms activate receptor splice forms that are expressed in mesenchymal regions of mouse development. Development 121, 3603–3613 (1995).
  CAS PubMed Google Scholar
• Xu, J., Lawshe, A., MacArthur, C. A. & Ornitz, D. M. Genomic structure, mapping, activity and expression of fibroblast growth factor 17. Mech. Dev. 83, 165–178 (1999).
  Article CAS PubMed Google Scholar
• Sato, T., Araki, I. & Nakamura, H. Inductive signal and tissue responsiveness defining the tectum and the cerebellum. Development 128, 2461–2469 (2001).
  CAS PubMed Google Scholar
• Lee, S. M., Danielian, P. S., Fritzsch, B. & McMahon, A. P. Evidence that FGF8 signalling from the midbrain-hindbrain junction regulates growth and polarity in the developing midbrain. Development 124, 959–969 (1997).
  CAS PubMed Google Scholar
• Liu, A., Losos, K. & Joyner, A. L. FGF8 can activate Gbx2 and transform regions of the rostral mouse brain into a hindbrain fate. Development 126, 4827–4838 (1999).
  CAS PubMed Google Scholar
• Christen, B. & Slack, J. M. FGF-8 is associated with anteroposterior patterning and limb regeneration in Xenopus. Dev. Biol. 192, 455–466 (1997).
  Article CAS PubMed Google Scholar
• Fletcher, R. B., Baker, J. C. & Harland, R. M. FGF8 spliceforms mediate early mesoderm and posterior neural tissue formation in Xenopus. Development 133, 1703–1714 (2006).
  Article CAS PubMed Google Scholar
• Falardeau, J. et al. Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J. Clin. Invest. 118, 2822–2831 (2008). Implicates decreased FGF8 signalling in the deficiency of gonadotropin-releasing hormone that underlies idiopathic hypogonadotropic hypogonadism and presents an example for the role of N-terminal alternative splicing in regulating the biological activity of FGF8.
  Article CAS PubMed PubMed Central Google Scholar
• Shimada, T. et al. Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology 143, 3179–3182 (2002).
  Article CAS PubMed Google Scholar
• White, K. E. et al. Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int. 60, 2079–2086 (2001).
  Article CAS PubMed Google Scholar
• Seidah, N. G. & Prat, A. The biology and therapeutic targeting of the proprotein convertases. Nature Rev. Drug Discov. 11, 367–383 (2012).
  Article CAS Google Scholar
• Gram Schjoldager, K. T. et al. A systematic study of site-specific GalNAc-type _O_-glycosylation modulating proprotein convertase processing. J. Biol. Chem. 286, 40122–40132 (2011).
  Article CAS PubMed Central Google Scholar
• White, K. E. et al. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nature Genet. 26, 345–348 (2000). Identifies FGF23 as a phosphaturic hormone and missense mutations at the proteolytic cleavage site of FGF23 as the cause for the renal phosphate wasting disease autosomal dominant hypophosphatemic rickets.
  Article CAS Google Scholar
• Frishberg, Y. et al. Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of _O_-glycosylation associated with augmented processing of fibroblast growth factor 23. J. Bone Miner. Res. 22, 235–242 (2007).
  Article CAS PubMed Google Scholar
• Kato, K. et al. Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires _O_-glycosylation. J. Biol. Chem. 281, 18370–18377 (2006).
  Article CAS PubMed Google Scholar
• Hsu, Y. R. et al. Human keratinocyte growth factor recombinantly expressed in Chinese hamster ovary cells: isolation of isoforms and characterization of post-translational modifications. Protein Expr. Purif. 12, 189–200 (1998).
  Article CAS PubMed Google Scholar
• Kim, G. Y. et al. HtrA1 is a novel antagonist controlling FGF signaling via cleavage of FGF8. Mol. Cell. Biol. 4 Sept 2012 (doi:10.1128/MCB.00872-12).
• Avivi, A., Yayon, A. & Givol, D. A novel form of FGF receptor-3 using an alternative exon in the immunoglobulin domain III. FEBS Lett. 330, 249–252 (1993).
  Article CAS PubMed Google Scholar
• Chellaiah, A. T., McEwen, D. G., Werner, S., Xu, J. & Ornitz, D. M. Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1. J. Biol. Chem. 269, 11620–11627 (1994).
  CAS PubMed Google Scholar
• Johnson, D. E., Lu, J., Chen, H., Werner, S. & Williams, L. T. The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol. Cell. Biol. 11, 4627–4634 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Miki, T. et al. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc. Natl Acad. Sci. USA 89, 246–250 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• Orr-Urtreger, A. et al. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev. Biol. 158, 475–486 (1993).
  Article CAS PubMed Google Scholar
• Yan, G., Fukabori, Y., McBride, G., Nikolaropolous, S. & McKeehan, W. L. Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)–FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol. Cell. Biol. 13, 4513–4522 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Yayon, A. et al. A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold. EMBO J. 11, 1885–1890 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• Wuechner, C., Nordqvist, A. C., Winterpacht, A., Zabel, B. & Schalling, M. Developmental expression of splicing variants of fibroblast growth factor receptor 3 (FGFR3) in mouse. Int. J. Dev. Biol. 40, 1185–1188 (1996).
  CAS PubMed Google Scholar
• Zhang, X. et al. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J. Biol. Chem. 281, 15694–15700 (2006).
  Article CAS PubMed Google Scholar
• Alarid, E. T. et al. Keratinocyte growth factor functions in epithelial induction during seminal vesicle development. Proc. Natl Acad. Sci. USA 91, 1074–1078 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Colvin, J. S., White, A. C., Pratt, S. J. & Ornitz, D. M. Lung hypoplasia and neonatal death in _Fgf9_-null mice identify this gene as an essential regulator of lung mesenchyme. Development 128, 2095–2106 (2001).
  CAS PubMed Google Scholar
• De Moerlooze, L. et al. An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal–epithelial signalling during mouse organogenesis. Development 127, 483–492 (2000).
  CAS PubMed Google Scholar
• Min, H. et al. Fgf-10 is required for both limb and lung development and exhibits striking functional similarity to Drosophila branchless. Genes Dev. 12, 3156–3161 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Sekine, K. et al. Fgf10 is essential for limb and lung formation. Nature Genet. 21, 138–141 (1999).
  Article CAS PubMed Google Scholar
• Xu, X. et al. Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. Development 125, 753–765 (1998). Provides genetic evidence for the crucial role of FGFR2 in bidirectional paracrine FGF signalling between the epithelium and the mesenchyme that initiates the outgrowth of limb buds.
  CAS PubMed Google Scholar
• Zhang, X. et al. Reciprocal epithelial–mesenchymal FGF signaling is required for cecal development. Development 133, 173–180 (2006).
  Article CAS PubMed Google Scholar
• Plotnikov, A. N., Hubbard, S. R., Schlessinger, J. & Mohammadi, M. Crystal structures of two FGF–FGFR complexes reveal the determinants of ligand-receptor specificity. Cell 101, 413–424 (2000).
  Article CAS PubMed Google Scholar
• Wang, F., Kan, M., Xu, J., Yan, G. & McKeehan, W. L. Ligand-specific structural domains in the fibroblast growth factor receptor. J. Biol. Chem. 270, 10222–10230 (1995).
  Article CAS PubMed Google Scholar
• Lajeunie, E. et al. FGFR2 mutations in Pfeiffer syndrome. Nature Genet. 9, 108 (1995).
  Article CAS PubMed Google Scholar
• Nagase, T., Nagase, M., Hirose, S. & Ohmori, K. Mutations in fibroblast growth factor receptor 2 gene and craniosynostotic syndromes in Japanese children. J. Craniofac. Surg. 9, 162–170 (1998).
  Article CAS PubMed Google Scholar
• Ibrahimi, O. A. et al. Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities. Hum. Mol. Genet. 13, 2313–2324 (2004).
  Article CAS PubMed Google Scholar
• Olsen, S. K. et al. Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity. Proc. Natl Acad. Sci. USA 101, 935–940 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Plotnikov, A. N., Schlessinger, J., Hubbard, S. R. & Mohammadi, M. Structural basis for FGF receptor dimerization and activation. Cell 98, 641–650 (1999).
  Article CAS PubMed Google Scholar
• Stauber, D. J., DiGabriele, A. D. & Hendrickson, W. A. Structural interactions of fibroblast growth factor receptor with its ligands. Proc. Natl Acad. Sci. USA 97, 49–54 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Goetz, R. et al. Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor. J. Biol. Chem. 287, 29134–29146 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Ito, S., Fujimori, T., Hayashizaki, Y. & Nabeshima, Y. Identification of a novel mouse membrane-bound family 1 glycosidase-like protein, which carries an atypical active site structure. Biochim. Biophys. Acta 1576, 341–345 (2002).
  Article CAS PubMed Google Scholar
• Ito, S. et al. Molecular cloning and expression analyses of mouse βKlotho, which encodes a novel Klotho family protein. Mech. Dev. 98, 115–119 (2000).
  Article CAS PubMed Google Scholar
• Kuro-o, M. et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45–51 (1997).
  Article CAS PubMed Google Scholar
• Yahata, K. et al. Molecular cloning and expression of a novel Klotho-related protein. J. Mol. Med. (Berl.) 78, 389–394 (2000).
  Article CAS Google Scholar
• Henrissat, B. A classification of glycosyl hydrolases based on amino acid sequence similarities. Biochem. J. 280, 309–316 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Henrissat, B. & Bairoch, A. New families in the classification of glycosyl hydrolases based on amino acid sequence similarities. Biochem. J. 293, 781–788 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Henrissat, B. & Bairoch, A. Updating the sequence-based classification of glycosyl hydrolases. Biochem. J. 316, 695–696 (1996).
  Article PubMed PubMed Central Google Scholar
• Fon Tacer, K. et al. Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol. Endocrinol. 24, 2050–2064 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Goetz, R. et al. Klotho coreceptors inhibit signaling by paracrine fibroblast growth factor 8 subfamily ligands. Mol. Cell. Biol. 32, 1944–1954 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Kharitonenkov, A. et al. FGF-21/FGF-21 receptor interaction and activation is determined by βKlotho. J. Cell. Physiol. 215, 1–7 (2008).
  Article CAS PubMed Google Scholar
• Li, S. A. et al. Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice. Cell Struct. Funct. 29, 91–99 (2004).
  Article CAS PubMed Google Scholar
• Machado, M. F. et al. Regulation and action of fibroblast growth factor 17 in bovine follicles. J. Endocrinol. 202, 347–353 (2009).
  Article CAS PubMed Google Scholar
• Portela, V. M. et al. Expression and function of fibroblast growth factor 18 in the ovarian follicle in cattle. Biol. Reprod. 83, 339–346 (2010).
  Article CAS PubMed Google Scholar
• Gabrielsson, B. G. et al. Depot-specific expression of fibroblast growth factors in human adipose tissue. Obes. Res. 10, 608–616 (2002).
  Article CAS PubMed Google Scholar
• Jaskoll, T. et al. FGF10/FGFR2b signaling plays essential roles during in vivo embryonic submandibular salivary gland morphogenesis. BMC Dev. Biol. 5, 11 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Mailleux, A. A. et al. Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryo. Development 129, 53–60 (2002).
  CAS PubMed Google Scholar
• Qiao, J. et al. FGF-7 modulates ureteric bud growth and nephron number in the developing kidney. Development 126, 547–554 (1999).
  CAS PubMed Google Scholar
• Terauchi, A. et al. Distinct FGFs promote differentiation of excitatory and inhibitory synapses. Nature 465, 783–787 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Dutchak, P. A. et al. Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones. Cell 148, 556–567 (2012). Identifies FGF21 as a mediator of the metabolic actions of PPARγ and hence provides new insight into the mechanism of action of the thiazolidinedione class of antidiabetic drugs, which are PPARγ agonists.
  Article CAS PubMed PubMed Central Google Scholar
• Tontonoz, P. & Spiegelman, B. M. Fat and beyond: the diverse biology of PPARγ. Annu. Rev. Biochem. 77, 289–312 (2008).
  Article CAS PubMed Google Scholar
• Hotta, Y. et al. Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. Endocrinology 150, 4625–4633 (2009).
  Article CAS PubMed Google Scholar
• Ming, A. Y. et al. Dynamics and distribution of Klothoβ (KLB) and fibroblast growth factor receptor-1 (FGFR1) in living cells reveal the fibroblast growth factor-21 (FGF21)-induced receptor complex. J. Biol. Chem. 287, 19997–20006 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Kouhara, H. et al. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 89, 693–702 (1997).
  Article CAS PubMed Google Scholar
• Lamothe, B. et al. The docking protein Gab1 is an essential component of an indirect mechanism for fibroblast growth factor stimulation of the phosphatidylinositol 3-kinase/Akt antiapoptotic pathway. Mol. Cell. Biol. 24, 5657–5666 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Brunet, A. et al. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96, 857–868 (1999).
  Article CAS PubMed Google Scholar
• Datta, S. R. et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231–241 (1997).
  Article CAS PubMed Google Scholar
• Hartwig, J. H. et al. MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin. Nature 356, 618–622 (1992).
  Article CAS PubMed Google Scholar
• Li, H., Rao, A. & Hogan, P. G. Interaction of calcineurin with substrates and targeting proteins. Trends Cell Biol. 21, 91–103 (2011).
  Article CAS PubMed Google Scholar
• Ye, S. et al. Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs. Biochemistry 40, 14429–14439 (2001).
  Article CAS PubMed Google Scholar